Advantis Corp. Delivers LipMedRX to Southern California Retailer

SANTA ANA, CA--(Marketwired - Feb 22, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) delivered the first order of LipMedRX Anti-Flu & Cold Lip Balm Protectant to its pilot 7-Eleven and 76 gas station last week, and is now available for retail sale.

Advantis Corp. has an exclusive distribution agreement with LipMedRX, and the delivery of their lip balm to the Southern California 7-Eleven and 76 gas station is the first time it will be available for retail purchase. The company plans on completing more deliveries and securing agreements with additional stores in the coming weeks. "Advantis has fulfilled its first purchase order with 7-Eleven and 76 Gas Stations," Advantis Corp. CEO, Jeremy Foti, said. "There will be many more to come, and we are currently negotiating with several national and international chain stores. I am proud to bring this revolutionary Anti-Flu & Cold Lip Balm Protectant to market, and we are excited to fill the overwhelming demand for this product."

LipMedRX is an innovative anti-germ lip balm protectant, which studies have shown to be highly effective in killing those germs associated with the flu and the common cold. According to a report released by LipMedRX, LLC, the Anti-Flu & Cold Lip Balm Protectant is the first ever lip balm that kills germs on the lips before they can enter the body. The product was designed to provide protection from germs while acting as a moisturizing agent that keeps lips soft and smooth.

Foti said they wanted to launch the product in a controlled distribution environment before spreading the product to retail outlets throughout the US and internationally. "We will effectively gauge consumer demand and we are targeting ideal retail chains for further distribution," Foti explained. "We are implementing a proven marketing strategy that will ensure escalating revenues. A product like this is long overdue and will soon be available internationally." Foti later added that Advantis Corp. will be making the lip balm available for retail sale, as well as at the wholesale level.

ABOUT Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes domestic and international partnerships with businesses that develop and sell proprietary consumer products and services. Product lines for consumer health care, music and entertainment sectors are in development.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.